Publication Name	World Journal of Clinical Oncology
Manuscript ID	28882
Country	France

Received	2016-07-20 14:37
Peer-Review Started	2016-07-21 14:18
To Make the First Decision	2016-09-05 09:13
Return for Revision	2016-09-05 17:11
Revised	2016-09-16 22:39
Second Decision	2016-09-28 11:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-10-18 16:36
Articles in Press	2016-10-18 16:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-03-30 14:42
Publish the Manuscript Online	2017-04-07 08:24

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Targeted therapies in breast cancer: New challenges to fight against resistance
Manuscript Source	Unsolicited Manuscript
All Author List	Viviana Masoud and Gilles Pagès
Funding Agency and Grant Number	Funding Agency Grant Number French Association for Cancer Research (ARC) Fondation de France French National Institute for Cancer Research (INCA) Fondation Estée Lauder (Pink Ribbon Award) Roche France and “Cordon de Vie” Monaco
Corresponding Author	Gilles Pagès, PhD, Director of Research INSERM, University Nice Sophia Antipolis, Institute for Research on Cancer and Aging of Nice CNRS UMR7284/INSERM U 1081, Centre Antoine Lacassagne 33 Avenue de Valombrose, 06189 Nice, France. gpages@unice.fr
Key Words	Breast cancers; Resistance; Human epidermal growth factor receptor 2; Angiogenesis; Triple negative; Immune tolerance
Core Tip	There are several reviews in the literature dedicated to breasts cancers. However, our manuscript is an updated review on the current knowledge and particularly on the molecular mechanisms involved in the relapse of patients on the current treatments. A summary of ongoing clinical trials gives a perspective for future therapeutic strategies. Our manuscript represents a working document for researchers/oncologists in the field of breast cancers.
Publish Date	2017-04-07 08:24
Citation	Masoud V, Pagès G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol 2017; 8(2): 120-134
URL	http://www.wjgnet.com/2218-4333/full/v8/i2/120.htm
DOI	http://dx.doi.org/10.5306/wjco.v8.i2.120

Full Article (PDF)	WJCO-8-120.pdf
Full Article (Word)	WJCO-8-120.doc
Manuscript File	28882-Review.docx
Answering Reviewers	28882-Answering reviewers.pdf
Audio Core Tip	28882-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	28882-Conflict-of-interest statement.pdf
Copyright License Agreement	28882-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	28882-Grant application form(s).pdf
Peer-review Report	28882-Peer-review(s).pdf
Scientific Misconduct Check	28882-Scientific misconduct check.pdf
Scientific Editor Work List	28882-Scientific editor work list.pdf